1-205303821-C-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_030952.3(NUAK2):​c.1516G>A​(p.Gly506Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000838 in 1,598,390 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00047 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000043 ( 0 hom. )

Consequence

NUAK2
NM_030952.3 missense

Scores

3
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.23
Variant links:
Genes affected
NUAK2 (HGNC:29558): (NUAK family kinase 2) Enables ATP binding activity; magnesium ion binding activity; and protein serine/threonine kinase activity. Involved in several processes, including cellular response to glucose starvation; negative regulation of apoptotic process; and protein phosphorylation. Predicted to be active in cytoplasm. Implicated in anencephaly. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.020591885).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NUAK2NM_030952.3 linkc.1516G>A p.Gly506Ser missense_variant Exon 7 of 7 ENST00000367157.6 NP_112214.3 Q9H093B4E0Y5
NUAK2XM_047431309.1 linkc.1120G>A p.Gly374Ser missense_variant Exon 6 of 6 XP_047287265.1
NUAK2XM_005245515.5 linkc.775G>A p.Gly259Ser missense_variant Exon 3 of 3 XP_005245572.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NUAK2ENST00000367157.6 linkc.1516G>A p.Gly506Ser missense_variant Exon 7 of 7 1 NM_030952.3 ENSP00000356125.5 Q9H093

Frequencies

GnomAD3 genomes
AF:
0.000473
AC:
72
AN:
152176
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00152
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000151
AC:
36
AN:
238838
Hom.:
0
AF XY:
0.0000773
AC XY:
10
AN XY:
129332
show subpopulations
Gnomad AFR exome
AF:
0.00200
Gnomad AMR exome
AF:
0.0000623
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000697
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000429
AC:
62
AN:
1446096
Hom.:
0
Cov.:
43
AF XY:
0.0000376
AC XY:
27
AN XY:
718348
show subpopulations
Gnomad4 AFR exome
AF:
0.00155
Gnomad4 AMR exome
AF:
0.000118
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000237
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000672
GnomAD4 genome
AF:
0.000473
AC:
72
AN:
152294
Hom.:
0
Cov.:
33
AF XY:
0.000483
AC XY:
36
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.00152
Gnomad4 AMR
AF:
0.000523
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.0000920
Hom.:
0
Bravo
AF:
0.000563
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000132
AC:
16
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 10, 2022
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.1516G>A (p.G506S) alteration is located in exon 7 (coding exon 7) of the NUAK2 gene. This alteration results from a G to A substitution at nucleotide position 1516, causing the glycine (G) at amino acid position 506 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
18
DANN
Benign
0.75
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.16
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Uncertain
0.87
D
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.021
T
MetaSVM
Benign
-0.65
T
PrimateAI
Uncertain
0.53
T
REVEL
Benign
0.21
Sift4G
Benign
0.41
T
Vest4
0.15
MVP
0.79
MPC
0.33
ClinPred
0.031
T
GERP RS
4.9
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139426041; hg19: chr1-205272949; API